Show simple item record

dc.contributor.authorSiddiqui, M.A.
dc.contributor.authorOgo, T.
dc.contributor.authorNasim, Md. Talat
dc.date.accessioned2016-03-21T14:45:52Z
dc.date.available2016-03-21T14:45:52Z
dc.date.issued2012
dc.identifier.citationSiddiqui MA, Ogo T and Nasim MT (2012) Pulmonary arterial hypertension: molecular genetic basis and emerging treatments. Anwer Khan Modern Medical College Journal. 3(2): 30-33.en_US
dc.identifier.urihttp://hdl.handle.net/10454/7971
dc.descriptionYesen_US
dc.description.abstractPulmonary arterial hypertension (PAH) is a rare cardiovascular disorder caused by narrowing of blood vessels in the lung and in the absence of therapy leads to right heart failure and death. No cure for this devastating disorder is known. The major objective of the current treatments is to improve symptoms and these therapies were developed prior to the discovery that this disease has substantial genetic components. In this review, we discuss molecular genetic basis of PAH together with pathobiology, current and future therapeutic interventions.en_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttp://dx.doi.org/10.3329/akmmcj.v3i2.11691en_US
dc.rights© 2012 AKMMC Journal. Full-text reproduced in accordance with the publisher’s self-archiving policy.en_US
dc.subjectPAH; Pulmonary arterial hypertension; Molecular geneticsen_US
dc.titlePulmonary arterial hypertension: molecular genetic basis and emerging treatmentsen_US
dc.status.refereedYesen_US
dc.typeArticleen_US
dc.type.versionAccepted Manuscripten_US
refterms.dateFOA2018-07-25T12:17:47Z


Item file(s)

Thumbnail
Name:
nasim_pulmonary.pdf
Size:
195.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record